You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thermosensitive Liposome

Showing 1 - 25 of 247
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Prague, Haifa, Candiolo (drug, radiation, device)

Withdrawn
  • Breast Cancer
  • ThermoDox (Thermally Sensitive Liposomal Doxorubicin)
  • +2 more
  • Prague, Czechia
  • +2 more
Mar 29, 2022

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV, Pancreatic Cancer Non-resectable Trial in Oxford (Focused

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Focused Ultrasound
  • +2 more
  • Oxford, United Kingdom
    Oxford University Hospitals NHS Trust
Feb 22, 2022

Metastatic Breast Cancer, Breast Cancer, Breast Tumors Trial in Utrecht (LTLD, MR-HIFU induced hyperthermia, Cyclophosphamide)

Recruiting
  • Metastatic Breast Cancer
  • +7 more
  • Utrecht, Netherlands
    University Medical Center Utrecht
Feb 16, 2021

Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023

Small Cell Lung Cancer Trial in Worldwide (Irinotecan liposome injection, Topotecan)

Active, not recruiting
  • Small Cell Lung Cancer
  • Denver, Colorado
  • +117 more
Nov 22, 2022

Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

Recruiting
  • Mycobacterium Infections, Nontuberculous
  • Birmingham, Alabama
  • +172 more
Jan 23, 2023

Lung Cancer Trial in Shanghai (Bupivacaine Liposome SAPB, Traditional TPVB)

Recruiting
  • Lung Cancer
  • Bupivacaine Liposome SAPB
  • Traditional TPVB
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Nov 15, 2023

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Completed
Has Results
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +8 more
  • Bevacizumab
  • Irinotecan Sucrosofate
  • Chicago, Illinois
    Northwestern University
Dec 21, 2022

Relapsing Multiple Sclerosis Trial in Beijing (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Mitoxantrone Hydrochloride Liposome Injection
  • Beijing, Beijing, China
    Xuanwu Hospital Capital Medical University
Aug 9, 2022

Neuromyelitis Optica Spectrum Disorder Trial (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • Mitoxantrone Hydrochloride Liposome Injection
  • (no location specified)
Sep 20, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

DLBCL Trial in Jinan (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Jinan, Shandong, China
    Affiliated Cancer Hospital of Shandong First Medical University
May 16, 2023

Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)

Active, not recruiting
Has Results
  • Lymphoid Leukemia
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

Not yet recruiting
  • Relapsed Small Cell Lung Cancer
  • Irinotecan hydrochloride liposome Injection
  • Topotecan
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 1, 2023

Relapsed/Refractory Multiple Myeloma Trial in Suzhou (Mitoxantrone HCl liposome/Dexamethasone/daratumumab)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Mitoxantrone hydrochloride liposome/Dexamethasone/daratumumab
  • Suzhou, Jiangsu, China
    Second Affiliated Hospital of Soochow University
May 4, 2023

Advanced Breast Cancer Trial in Shijiazhuang (Doxorubicin HCl liposome injection)

Completed
  • Advanced Breast Cancer
  • Doxorubicin hydrochloride liposome injection
  • Shijiazhuang, China
    The Fourth Hospital of Hebei Medical University
Oct 18, 2023

Acute Myeloid Leukemia Trial in Tianjin ((cytarabine: daunorubicin) liposome for injection, Vyxeos)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (cytarabine: daunorubicin) liposome for injection
  • Vyxeos
  • Tianjin, China
    Institute of Hematology and Hospital of Blood Disease, Chinese A
Mar 24, 2023

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • (no location specified)
May 29, 2023

Bioequivalence Trial in Haikou (Amphotericin B liposome for injection, AmBisome)

Active, not recruiting
  • Bioequivalence
  • Amphotericin B liposome for injection
  • AmBisome
  • Haikou, Hainan, China
    Haikou people's Hospital
Jun 12, 2023

Lower Extremity Revascularization Trial in Eau Claire (Bupivacaine liposome, Placebo)

Not yet recruiting
  • Lower Extremity Revascularization
  • Bupivacaine liposome
  • Placebo
  • Eau Claire, Wisconsin
    Mayo Clinic Health System - Eau Claire
Aug 7, 2023

Pain, Postoperative, Opioid Use, Perioperative Complication Trial (bupivacaine liposome injectable suspension, Bupivacaine

Not yet recruiting
  • Pain, Postoperative
  • +3 more
  • bupivacaine liposome injectable suspension
  • Bupivacaine Hydrochloride
  • (no location specified)
Oct 4, 2023

Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)

Not yet recruiting
  • Autologous Stem Cell Transplantation
  • Conditioning
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023

Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Cyclophosphamide)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • (no location specified)
Mar 9, 2023

Solid Tumors, Adult Trial in Dallas, Hangzhou (HF158K1 /Arm 2 mg/m², HF158K1 /Arm 6 mg/m², HF158K1 /Arm 15 mg/m²)

Not yet recruiting
  • Solid Tumors, Adult
  • HF158K1 /Arm 2 mg/m²
  • +5 more
  • Dallas, Texas
  • +2 more
May 6, 2023